The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage

References

• Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69:88–112.
   PubMed Web of Science ®Google Scholar
• Budny A, Grochowski C, Kozłowski P, et al. Obesity as a tumour development triggering factor. Ann Agric Environ Med. 2019;26:13–23.
   PubMed Web of Science ®Google Scholar
• Chaput JP, Saunders TJ, Tremblay MS, et al. Workplace standing time and the incidence of obesity and type 2 diabetes: a longitudinal study in adults. BMC Public Health. 2015;15:111.
   PubMed Web of Science ®Google Scholar
• Lycett D. The Association of religious affiliation and body mass index (BMI): an analysis from the health survey for England. J Relig Health. 2015;54:2249–2267.
   PubMed Web of Science ®Google Scholar
• Vrieling A, Kampman E, Knijnenburg NC, et al. Body composition in relation to clinical outcomes in renal cell cancer: a systematic review and meta-analysis. Eur Urol Focus. 2018;4:420–434.
   PubMedGoogle Scholar
• Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020;8:616–627.
   PubMed Web of Science ®Google Scholar
• Aurilio G, Piva F, Santoni M, et al. The role of obesity in renal cell carcinoma patients: clinical-pathological implications. Int J Mol Sci. 2019;20:5683.
   Web of Science ®Google Scholar
• Arabsalmani M, Mohammadian-Hafshejani A, Ghoncheh M, et al. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern. J Nephropathol. 2017;6:30–42.
   PubMedGoogle Scholar
• Kabaria R, Klaassen Z, Terris MK. Renal cell carcinoma: links and risks. Int J Nephrol Renovasc Dis. 2016;9:45–52.
   PubMed Web of Science ®Google Scholar
• Kaneko G, Miyajima A, Yuge K, et al. Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma. Jpn J Clin Oncol. 2015;45:210–216.
   PubMed Web of Science ®Google Scholar
• Steffens S, Grünwald V, Ringe KI, et al. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy? Oncologist. 2011;16:1565–1571.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Fried SK. Sex-dependent depot differences in adipose tissue development and function; role of sex steroids. J Obes Metab Syndr. 2017;26:172–180.
   PubMed Web of Science ®Google Scholar
• Hu ZX, Wu JL, Lai SS, et al. Clear cell renal cell carcinoma: the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade. Eur Radiol. 2020;30:3977–3986.
   PubMed Web of Science ®Google Scholar
• Ebadi M, Mazurak VC. Evidence and mechanisms of fat depletion in cancer. Nutrients. 2014;6:5280–5297.
   PubMed Web of Science ®Google Scholar
• Ozoya OO, Siegel EM, Srikumar T, et al. Quantitative assessment of visceral obesity and postoperative colon cancer outcomes. J Gastrointest Surg. 2017;21(3):534–542.
   PubMed Web of Science ®Google Scholar
• Parker WP, Cheville JC, Frank I, et al. Application of the Stage, Size, Grade, and Necrosis (SSIGN) score for clear cell renal cell carcinoma in contemporary patients. Eur Urol. 2017;71:665–673.
   PubMed Web of Science ®Google Scholar
• Xia AD, Chen YM, Chen JF, et al. Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy. J Cancer. 2019;10:5494–5503.
   PubMed Web of Science ®Google Scholar
• Yuge K, Miyajima A, Jinzaki M, et al. How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy? Jpn J Clin Oncol. 2015;45:373–377.
   PubMed Web of Science ®Google Scholar
• Lee HW, Jeong BC, Seo SI, et al. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy. Int J Urol. 2015;22:455–461.
   PubMed Web of Science ®Google Scholar
• Rollins KE, Javanmard-Emamghissi H, Awwad A, et al. Body composition measurement using computed tomography: does the phase of the scan matter? Nutrition. 2017;41:37–44.
   PubMed Web of Science ®Google Scholar
• Paris MT, Furberg HF, Petruzella S, et al. Influence of contrast administration on computed tomography–based analysis of visceral adipose and skeletal muscle tissue in clear cell renal cell carcinoma. JPEN J Parenter Enteral Nutr. 2018;42:1148–1155.
   PubMed Web of Science ®Google Scholar
• Nguyen GK, Mellnick VM, Yim AKY, et al. Synergy of sex differences in visceral fat measured with CT and tumor metabolism helps predict overall survival in patients with renal cell carcinoma. Radiology. 2018;287:884–892.
   PubMed Web of Science ®Google Scholar
• Lowrance WT, Thompson RH, Yee DS, et al. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int. 2010;105:16–20.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–480.
   PubMed Web of Science ®Google Scholar
• Otunctemur A, Dursun M, Ozer K, et al. Renal cell carcinoma and visceral adipose index: a new risk parameter. Int Braz J Urol. 2016;42:955–959.
   PubMed Web of Science ®Google Scholar
• Keehn A, Srivastava A, Maiman R, et al. The relationship between visceral obesity and the clinicopathologic features of patients with small renal masses. J Endourol. 2015;29:372–376.
   PubMed Web of Science ®Google Scholar
• Wang HK, Song XS, Cheng Y, et al. Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China. BJU Int. 2014;114:496–502.
   PubMed Web of Science ®Google Scholar
• Williamson SR, Taneja K, Cheng L. Renal cell carcinoma staging: pitfalls, challenges,and updates. Histopathology. 2019;74:18–30.
   PubMed Web of Science ®Google Scholar
• Santoni M, Cimadamore A, Massari F, et al. Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers. Cancers (Basel). 2019;11:1225.
   PubMed Web of Science ®Google Scholar
• Zi X, Lusch A, Blair CA, et al. Effect of perineoplasm perinephric adipose tissues on migration of clear cell renal cell carcinoma cells: a potential role of WNT signaling. Oncotarget. 2016;7:53277–53288.
   PubMedGoogle Scholar
• Mizuno R, Miyajima A, Hibi T, et al. Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy. Med Oncol. 2017;34:47.
   PubMed Web of Science ®Google Scholar
• Choueiri TK, Xie W, Kollmannsberger CK, et al. The impact of body mass index (BMI) and body surface area (BSA) on treatment outcome to vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma: results from a large international collaboration. J Clin Oncol. 2010;28:4524.
   Web of Science ®Google Scholar
• Prado CM, Gonzalez MC, Heymsfield SB. Body composition phenotypes and obesity paradox. Curr Opin Clin Nutr Metab Care. 2015;18:535–551.
   PubMed Web of Science ®Google Scholar
• Gupta S. Obesity: the fat advantage. Nature. 2016;537:S100–102.
   PubMed Web of Science ®Google Scholar
• Brunner AM, Sadrzadeh H, Feng Y, et al. Association between baseline body mass index (BMI) and overall survival among patients over age 60 with acute myeloid leukemia (AML). Am J Hematol. 2013;88:642–646.
   PubMed Web of Science ®Google Scholar
• Amptoulach S, Gross G, Kalaitzakis E. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases. J Surg Res. 2015;199:378–385.
   PubMed Web of Science ®Google Scholar
• Lucca I, Klatte T, Fajkovic H, et al. Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol. 2015;12:585–592.
   PubMed Web of Science ®Google Scholar